Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1984-8-7
pubmed:abstractText
Band-3 glycoprotein was purified from human blood-group-A erythrocyte membranes by selective solubilization and gel chromatography on Sepharose 6B in the presence of sodium dodecyl sulphate. The purified glycoprotein was subjected to hydrazinolysis in order to release the carbohydrate moiety. The released oligosaccharides were N-acetylated and applied to a column of DEAE-cellulose. Most of the band-3 oligosaccharides obtained were found to be free of sialic acids. When this neutral fraction was subjected to gel chromatography on a column of Sephadex G-50, two broad peaks were observed indicating that the band-3 glycoprotein was heterogeneous in the size of the oligosaccharide moieties. All fractions from gel chromatography were found to contain galactose, mannose, N-acetylglucosamine and fucose. The higher-molecular-weight (mol.wt. 3000-8000) peak consisted of fucose, mannose, galactose, N-acetylglucosamine and N-acetylgalactosamine in a molar proportion of 1.6:3.0:8.4:10.5:0.2. Most of these oligosaccharides were digested with a mixture of beta-galactosidase and beta-N-acetylhexosaminidase after alpha-L-fucosidase treatment to give a small oligosaccharide with the structure alpha Man2-beta Man-beta GlcNAc-GlcNAc. Methylation studies and limited degradation by nitrous acid deamination showed that the oligosaccharides contained the repeating disaccharide Gal beta 1----4GlcNAc beta 1----3, with branching points at C-6 of some of the galactose residues. These results indicate that a major portion of the band-3 oligosaccharide has a common core structure, with heterogeneity in the numbers of the repeating disaccharides, and contains fucose residues both in the peripheral portion and in the core portion. Haemagglutination tests were also carried out to determine the blood-group specificities of the glycoprotein and the results demonstrated the presence of both blood-group-H and I antigenic activities.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/7188422-1016986, http://linkedlifedata.com/resource/pubmed/commentcorrection/7188422-1035216, http://linkedlifedata.com/resource/pubmed/commentcorrection/7188422-107170, http://linkedlifedata.com/resource/pubmed/commentcorrection/7188422-1112782, http://linkedlifedata.com/resource/pubmed/commentcorrection/7188422-1121325, http://linkedlifedata.com/resource/pubmed/commentcorrection/7188422-1167151, http://linkedlifedata.com/resource/pubmed/commentcorrection/7188422-1194279, http://linkedlifedata.com/resource/pubmed/commentcorrection/7188422-1263250, http://linkedlifedata.com/resource/pubmed/commentcorrection/7188422-14135466, http://linkedlifedata.com/resource/pubmed/commentcorrection/7188422-16748065, http://linkedlifedata.com/resource/pubmed/commentcorrection/7188422-4211043, http://linkedlifedata.com/resource/pubmed/commentcorrection/7188422-4326772, http://linkedlifedata.com/resource/pubmed/commentcorrection/7188422-438154, http://linkedlifedata.com/resource/pubmed/commentcorrection/7188422-4735853, http://linkedlifedata.com/resource/pubmed/commentcorrection/7188422-4781053, http://linkedlifedata.com/resource/pubmed/commentcorrection/7188422-4796658, http://linkedlifedata.com/resource/pubmed/commentcorrection/7188422-4834650, http://linkedlifedata.com/resource/pubmed/commentcorrection/7188422-4838037, http://linkedlifedata.com/resource/pubmed/commentcorrection/7188422-5062493, http://linkedlifedata.com/resource/pubmed/commentcorrection/7188422-5062716, http://linkedlifedata.com/resource/pubmed/commentcorrection/7188422-5476851, http://linkedlifedata.com/resource/pubmed/commentcorrection/7188422-5566420, http://linkedlifedata.com/resource/pubmed/commentcorrection/7188422-5666760, http://linkedlifedata.com/resource/pubmed/commentcorrection/7188422-5821838, http://linkedlifedata.com/resource/pubmed/commentcorrection/7188422-620075, http://linkedlifedata.com/resource/pubmed/commentcorrection/7188422-661598, http://linkedlifedata.com/resource/pubmed/commentcorrection/7188422-687374, http://linkedlifedata.com/resource/pubmed/commentcorrection/7188422-701248, http://linkedlifedata.com/resource/pubmed/commentcorrection/7188422-701260, http://linkedlifedata.com/resource/pubmed/commentcorrection/7188422-711733, http://linkedlifedata.com/resource/pubmed/commentcorrection/7188422-729592, http://linkedlifedata.com/resource/pubmed/commentcorrection/7188422-972154
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0264-6021
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
187
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
677-86
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1980
pubmed:articleTitle
The carbohydrate moiety of band-3 glycoprotein of human erythrocyte membranes.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't